
4D Molecular Therapeutics Inc (FDMT)’s latest performance is not what we had anticipated
A new trading day began on Monday, with 4D Molecular Therapeutics Inc (NASDAQ: FDMT) stock price down -4.94% from the previous day of trading, before
A new trading day began on Monday, with 4D Molecular Therapeutics Inc (NASDAQ: FDMT) stock price down -4.94% from the previous day of trading, before
A new trading day began on Tuesday, with 4D Molecular Therapeutics Inc (NASDAQ: FDMT) stock price down -9.63% from the previous day of trading, before
4D Molecular Therapeutics Inc (NASDAQ: FDMT) started the day on Thursday, with a price increase of 6.45% at $7.1, before settling in for the price
On Tuesday, 4D Molecular Therapeutics Inc (NASDAQ: FDMT) opened higher 11.21% from the last session, before settling in for the closing price of $5.53. Price
4D Molecular Therapeutics Inc (NASDAQ: FDMT) kicked off on Monday, down -18.38% from the previous trading day, before settling in for the closing price of
As on Thursday, 4D Molecular Therapeutics Inc (NASDAQ: FDMT) got off with the flyer as it spiked 2.04% to $4.5, before settling in for the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.